Transition From Ambrisentan To Bosentan In Pulmonary Arterial Hypertension: A Single Center Prospective Study

被引：0
|
作者：
Gong, S. -G. [1 ]
Wang, L. [1 ]
Bigyan, P. [1 ]
Yuan, P. [1 ]
Zhao, Q. -H. [1 ]
Rong, J. [1 ]
He, J. [1 ]
Wu, W. -H. [1 ]
Zhang, R. [1 ]
Liu, J. -M. [1 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2275
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Ambrisentan: a review of its use in pulmonary arterial hypertension
    Rivera-Lebron, Belinda N.
    Risbano, Michael G.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (06) : 233 - 244
  • [42] Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension
    Strange, Geoff
    Keogh, Anne
    Dalton, Brad
    Gabbay, Eli
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (03) : 253 - 263
  • [43] Bosentan in pulmonary arterial hypertension secondary to scleroderma
    Joglekar, A
    Tsai, FS
    McCloskey, DA
    Wilson, JE
    Seibold, JR
    Riley, DJ
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 61 - 68
  • [44] Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes
    Elshaboury, Soha M.
    Anderson, Joe R.
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 401 - 409
  • [45] Review of bosentan in the management of pulmonary arterial hypertension
    Gabbay, Eli
    Fraser, John
    McNeil, Keith
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (06) : 887 - 900
  • [46] Bosentan in Pediatric Patients with Pulmonary Arterial Hypertension
    Beghetti, Maurice
    CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (02) : 225 - 233
  • [47] Bosentan: In pediatric patients with pulmonary arterial hypertension
    Carter N.J.
    Keating G.M.
    Pediatric Drugs, 2010, 12 (1) : 63 - 73
  • [48] Ambrisentan In Portopulmonary Hypertension, Results From The Multicenter Prospective Angel Study (ambrisentan Usage In Portopulmonary Hypertension)
    Preston, I. R.
    Burger, C. D.
    Battarjee, W. F.
    Bartolome, S.
    Safdar, Z.
    Krowka, M.
    Sood, N.
    Ford, H. J.
    Gomberg-Maitland, M.
    Chakinala, M. M.
    Hill, N. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [49] Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
    McGoon, Michael D.
    Frost, Adaani E.
    Oudiz, Ronald J.
    Badesch, David B.
    Galie, Nazzareno
    Olschewski, Horst
    McLaughlin, Vallerie V.
    Gerber, Michael J.
    Dufton, Chris
    Despain, Darrin J.
    Rubin, Lewis J.
    CHEST, 2009, 135 (01) : 122 - 129
  • [50] Ambrisentan rescue therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function abnormalities
    McGoon, Michael D.
    Frost, Adaani E.
    Oudiz, Ronald J.
    Badesch, David B.
    Galie, Nazzareno
    Olschewski, Horst
    McLaughlin, Vallerie V.
    Rubin, Lewis J.
    CHEST, 2006, 130 (04) : 254S - 254S
12345